Ellsworth Advisors, LLC Charles River Laboratories International, Inc. Transaction History
Ellsworth Advisors, LLC
- $375 Million
- Q4 2024
A detailed history of Ellsworth Advisors, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Ellsworth Advisors, LLC holds 20,570 shares of CRL stock, worth $3.1 Million. This represents 1.01% of its overall portfolio holdings.
Number of Shares
20,570
Previous 20,788
1.05%
Holding current value
$3.1 Million
Previous $4.1 Million
7.28%
% of portfolio
1.01%
Previous 1.07%
Shares
2 transactions
Others Institutions Holding CRL
# of Institutions
710Shares Held
49.8MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$927 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$766 Million0.02% of portfolio
-
State Street Corp Boston, MA2.18MShares$328 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.81MShares$272 Million0.56% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.81MShares$272 Million0.79% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.66B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...